|
|
|
|
|
|
|
|
Abstract
Background:
Combined oral
contraceptive (COC) use reduces epithelial ovarian cancer (EOC) risk.
However, little is known about risk with COC use before the first
full-term pregnancy (FFTP).
Methods:
This Canadian population-based case–control study (2001–2012) included 854 invasive cases/2139 controls aged 40 years who were parous and had information on COC use. We estimated odds ratios (aORs) and 95% confidence intervals (CI) adjusted for study site, age, parity, breastfeeding, age at FFTP, familial breast/ovarian cancer, tubal ligation, and body mass.
Results:
Among parous women, per year of COC use exclusively before the FFTP was associated with a 9% risk reduction (95% CI=0.86–0.96). Results were similar for high-grade serous and endometrioid/clear cell EOC. In contrast, per year of use exclusively after the FFTP was not associated with risk (aOR=0.98, 95% CI=0.95–1.02).
Conclusions:
Combined
oral contraceptive use before the FFTP may provide a risk reduction
that remains for many years, informing possible prevention strategies.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.